Background. Numerous techniques have been developed for localizing lymph nodes before surgical resection and for their histological assessment. Nondestructive high-resolution transcapsule optical imaging of lymph nodes offers the potential for in situ assessment of metastatic involvement, potentially during surgical procedures. Methods. Three-dimensional optical coherence tomography (3-D OCT) was used for imaging and assessing resected popliteal lymph nodes from a preclinical rat metastatic tumor model over a 9-day time-course study after tumor induction. The spectral-domain OCT system utilized a center wavelength of 800 nm, provided axial and transverse resolutions of 3 and 12 lm, respectively, and performed imaging at 10,000 axial scans per second. Results. OCT is capable of providing high-resolution labelfree images of intact lymph node microstructure based on intrinsic optical scattering properties with penetration depths of *1-2 mm. The results demonstrate that OCT is capable of differentiating normal, reactive, and metastatic lymph nodes based on microstructural changes. The optical scattering and structural changes revealed by OCT from day 3 to day 9 after the injection of tumor cells into the lymphatic system correlate with inflammatory and immunological changes observed in the capsule, precortical regions, follicles, and germination centers found during histopathology. Conclusions. We report for the first time a longitudinal study of 3-D transcapsule OCT imaging of intact lymph nodes demonstrating microstructural changes during metastatic infiltration. These results demonstrate the potential of OCT as a technique for intraoperative, real-time in situ 3-D optical biopsy of lymph nodes for the intraoperative staging of cancer.
ABSTRACT
Background. Numerous techniques have been developed for localizing lymph nodes before surgical resection and for their histological assessment. Nondestructive high-resolution transcapsule optical imaging of lymph nodes offers the potential for in situ assessment of metastatic involvement, potentially during surgical procedures. Methods. Three-dimensional optical coherence tomography (3-D OCT) was used for imaging and assessing resected popliteal lymph nodes from a preclinical rat metastatic tumor model over a 9-day time-course study after tumor induction. The spectral-domain OCT system utilized a center wavelength of 800 nm, provided axial and transverse resolutions of 3 and 12 lm, respectively, and performed imaging at 10,000 axial scans per second. Results. OCT is capable of providing high-resolution labelfree images of intact lymph node microstructure based on intrinsic optical scattering properties with penetration depths of *1-2 mm. The results demonstrate that OCT is capable of differentiating normal, reactive, and metastatic lymph nodes based on microstructural changes. The optical scattering and structural changes revealed by OCT from day 3 to day 9 after the injection of tumor cells into the lymphatic system correlate with inflammatory and immunological changes observed in the capsule, precortical regions, follicles, and germination centers found during histopathology. Conclusions. We report for the first time a longitudinal study of 3-D transcapsule OCT imaging of intact lymph nodes demonstrating microstructural changes during metastatic infiltration. These results demonstrate the potential of OCT as a technique for intraoperative, real-time in situ 3-D optical biopsy of lymph nodes for the intraoperative staging of cancer.
Lymph nodes are highly specialized and vital immunological organs in the lymphatic system. They serve to filter and identify foreign particles and antigens to elicit an immunologic response. The assessment and status of lymph nodes serves as an important indicator for metastatic spread of cancer, for staging the extent of the disease to determine therapeutic regimens, and for making a prognosis. Lymph nodes have a well-defined and dynamically responsive microstructure with an outer capsule, subcapsular sinus, cortex containing follicles and B cells, paracortex containing T cells, medullary sinuses, medullary cords, and hilus. 1 A proper evaluation of their gross and microscopic features reflects the pathological condition of those parts of the body that drain to the respective nodes. Currently, the assessment of lymph nodes in surgical oncology is routinely performed postoperatively by a histopathologist, primarily to determine if there has been metastatic involvement.
Current clinical imaging modalities including X-ray, MRI, CT, ultrasound, and PET are considered as options for noninvasive in situ imaging of lymph nodes, with each having various advantages and disadvantages. However, the resolution of these modalities largely only permits the assessment of node size, and other than PET, the assessment of lymph nodes using these modalities mostly relies on lymph node anatomy rather than function and physiology. 2 The sizes of lymph nodes, along with some information about morphology, have been the primary differentiating criteria for nodal staging with these imaging modalities. However, this approach has low accuracy and cannot be used to reliably distinguish between node enlargement due to cancer or to inflammation. 3, 4 Also, the imaging resolution of these modalities is not sufficient to reveal lymph node microstructure and perform an in vivo assessment of any lymph node metastasis involving partial or microscopic infiltration of tumor cells, rather than only gross morphology. The use of contrast agents such as gadolinium and iron oxide nanoparticles in MRI has been explored for assessing alterations in lymph node microcirculation such as flow characteristics, blood volume, microvascular permeability, and increased fractional volume of the extravascular extracellular space. [5] [6] [7] [8] [9] However, these contrast agents take an extended period of time to distribute through the lymphatic system. None of the above mentioned methodologies currently enable the intraoperative assessment of lymph node status.
Several techniques have been developed to localize lymph nodes, primarily sentinel lymph nodes, before resection during cancer surgery. These have traditionally included the use of a radiotracer (technetium-99 m) or dye (methylene blue, Lymphazurin) and the use of near-infrared optical dyes coupled with intraoperative fluorescence imaging systems are currently being investigated. [10] [11] [12] [13] All of these methods, however, rely solely on identifying and localizing lymph nodes, rather than enabling an assessment of the lymph node status (normal, reactive, metastatic). Other optical techniques such as light and confocal microscopy in the operating room have been used to visualize lymph node specimens or touch preparations, but have required the resection and ex vivo bisection of the nodes to expose the microarchitecture for high-resolution imaging, and are not practical for in situ assessment. 14, 15 Optical coherence tomography (OCT) is an emerging in vivo imaging modality with typical axial and transverse resolutions of 1-5 lm and 10-15 lm, respectively, and the capability of providing real-time microscopic images up to 2 mm beneath the tissue surface, even in highly scattering tissues. [16] [17] [18] OCT has shown potential for use in high-resolution surgical guidance. [19] [20] [21] In addition, OCT has been previously used to image breast cancer tumor margins intraoperatively in human subjects, and other studies have shown the potential of OCT for imaging morphological features related to cancer metastasis and intraoperatively identifying metastatic nodes. [22] [23] [24] [25] In one study ex vivo human axillary lymph nodes were bisected to cut open the capsule structure and expose inner structures for imaging, while other work has focused on transcapsule imaging. [23] [24] [25] Though preliminary reports have been promising, no systematic studies have been performed to assess the capability of OCT for imaging changes that occur in the time-dependent progression of lymph node metastases.
Identifying OCT image-based microscopic structural changes that enable lymph node assessment and classification as normal, reactive, or metastatic would aid the clinical staging of the disease, with the potential for assessment and staging to occur in real-time, during surgical procedures.
Our primary aim for this study was to analyze the microstructural and pathological changes in intact lymph nodes at different stages of metastatic involvement using 3-D OCT, which is not possible from discrete human specimens in unpredictable or uncontrolled pathological stages. To accomplish this, we utilize a preclinical rat tumor metastases model to perform a controlled longitudinal time-dependent study of the progression of lymph node metastases. We performed transcapsule 3-D OCT imaging of physically intact popliteal lymph nodes resected from this rat tumor model, rather than bisecting nodes to expose internal microstructure. The metastatic lymph nodes were induced in this rat tumor metastasis model by injecting tumor cells into the hind leg foot pad of the animals, and popliteal lymph nodes were imaged ex vivo at day 3 to day 9 time points after injection. The 3-D OCT images were analyzed and compared with images from popliteal lymph nodes from control animals. Corresponding histopathological analysis was performed on all specimens in parallel. Our previous results have suggested that 3-D OCT could have significant potential for identifying early changes in lymph node morphology related to metastatic invasion based on the differences in the optical scattering properties of the tissue. 23, 25 This study is designed to explore if OCT can be used to image and assess lymph node status at various stages of metastatic involvement or infiltration, thus providing an atlas of optical image biomarkers that can be used in the future to compare with the real-time feedback and diagnostic image information acquired during surgical interventions.
MATERIALS AND METHODS

Animal Model
Experiments were performed in compliance with an experimental protocol approved by the Institutional Animal Care and Use Committee at the University of Illinois at Urbana-Champaign. Inbred Fischer F344 female rats (n = 10, 32 days old) (Harlan, Indianapolis, IN) were used in this study, providing two rats (two popliteal lymph nodes) per longitudinal time point. To induce metastasizing tumors and metastatic lymph nodes, tumor cells were injected into one hind-limb foot pad as previously described. 26 Briefly, rat mammary tumor cells (13762 MAT B III, ATCC #CRL-1666, *5 9 10 6 cells per animal) were injected into the left footpad (day 0) to form tumors that would develop in the footpad and metastasize to the popliteal lymph nodes through the lymphatic drainage network of the foot and leg. Results were referenced to control rats that received only saline injections into the footpad. The popliteal lymph nodes from the animals injected with tumor cells were imaged ex vivo using 3-D OCT on days 3, 5, 7, and 9 after injection. These time points were selected on the basis of a pilot study (3 rats injected with 5 9 10 5 tumor cells per animal) which showed that advanced metastatic disease was present in the lymph nodes on days 12 and 13 after injection. Before imaging, the animals were anesthetized by intraperitoneal injection with a combination of ketamine (100 mg/kg) and xylazine (10 mg/kg), and a 1 % isosulfan blue solution (Lymphazurin; U.S. Surgical Corp., Norwalk, CT) was injected into the footpad tumor site and allowed to circulate for 5 min to map out the lymphatic drainage system. Animals were sacrificed, and a portion of the footpad tumor along with right and left popliteal lymph nodes were removed and imaged by 3-D OCT. Histopathological evaluation of the popliteal lymph nodes was carried out after OCT imaging.
OCT Imaging
A spectral-domain OCT system was used for ex vivo imaging of lymph nodes. A femtosecond titanium:sapphire laser (KMLabs, Inc.) with a bandwidth of 110 nm centered at a wavelength of 800 nm providing an axial resolution of *3 lm was used as the light source. The laser was pumped by a frequency-doubled Nd:YVO 4 laser (Coherent Inc.) with 4.5 W of 532 nm light. The broadband light was launched into a single-mode fiber interferometer which was divided into the sample arm and a stationary reference arm. The sample arm beam was steered using galvanometermounted mirrors for 3-D OCT imaging. The samples were imaged with an achromatic lens with a focal length of 30 mm, producing a transverse resolution of *12 lm. The power in the sample arm was 10 mW. The interference of the reference and sample beams was measured with a spectrometer composed of a grating, imaging lens, and line camera (Piranha 2, Dalsa Inc.) with a capability of 33 kHz line acquisition rates. The spectrometer resolution was designed to provide an optical imaging depth of 2 mm. Two-dimensional B-mode imaging of the specimens, followed by transverse scanning in the third (y) direction with spacing of 10 lm using galvanometer mirrors, was performed to achieve 3-D reconstructions of the lymph nodes. Images were acquired at an axial scan rate of 10 kHz and a camera exposure time of 90 ls, with an image capture time of 0.4 s per cross-sectional B-mode image. A typical 3-D OCT data set contained 300 B-mode images in each volume. Significantly faster volumetric imaging is possible with recent advances in optical sources for OCT, enabling these 3-D volumes to be acquired in \1 s. 27, 28 En face images were computationally extracted from the 3-D volumes to illustrate lymph node features with resolution that was uniform in the x-y plane (*12 lm), in contrast to the cross-sectional (x-z) OCT images that had different resolutions in each direction (*12 lm and *3 lm, respectively). It should be noted that 3-D OCT was performed transcapsule, from resected but physically intact lymph nodes. This is in contrast to many other optical imaging studies where lymph nodes are bisected to expose inner structures for imaging. The transcapsule approach is intended to validate the potential for using 3-D OCT on in situ lymph nodes in the future.
The portable OCT system that would be used during surgery would be contained in a small cart and easily maneuvered into the operating room for imaging during procedures. OCT imaging would be performed in situ by a surgeon using a handheld surgical probe, or ex vivo by trained OR staff on any excised specimens. Real-time OCT images from the portable system would allow a surgeon to intraoperatively determine whether lymph nodes contain metastatic disease.
Histopathology Protocol
The lymph nodes were fixed in formalin, paraffin embedded, and sectioned at a thickness of 10 lm. The tissue sections were stained with hematoxylin and eosin. The histology slides were digitized using a light microscope (Carl Zeiss, Germany), and auto-stitched together (Adobe Photoshop CS4) to provide a single montage for illustration. The hematoxylin and eosin-stained histology slides were evaluated by a board-certified clinical pathologist and classified as normal, reactive, or metastatic. The histological processing and analysis were performed in a blinded fashion, without knowing the history of the animals.
RESULTS
The OCT images of all control lymph nodes clearly showed normal structure (Figs. 1, 2 ) featuring an intact capsule and follicular structures that were distinguishable from the background cortex on the basis of their spheroidal pattern of optical scattering. In addition, the outer adipose tissue, capsule, and precortical regions were distinct in the OCT images. Figure 1 presents a representative example of a 3-D OCT reconstruction of a normal lymph node, along with the cross-sectional (y-z and x-z) and en face (x-y) images. En face images showed more useful detail when compared to cross-sectional OCT images. This may be due to the uniform resolution available in the x-y plane, as compared to crosssectional images which had different resolutions along the depth and transverse axes. The features observed in the OCT images correlate well with the corresponding histological sections, and both served as a reference to identify architectural changes and stage metastatic infiltration in the images from the other animals.
The observed lymph node capsular structure becomes less distinct in the OCT and histology images of the lymph nodes on day 3 after the injection of tumor cells (Fig. 3) . Gross macroscopic inspection revealed mild inflammation of the lymph nodes. The histology verifies an infiltration of macrophages, but no clear evidence of anaplasia indicating the presence of tumor cells in the subcapsular space was found. There was also a mild increase in scattering from the follicles in the OCT images.
Lymph node images on day 5 after injection of tumor cells showed a disappearance and disruption of the capsule, and the appearance of a new heterogeneous low-scattering layer in the subcapsular space (Fig. 4) . In these images, all the follicles are clearly visible and highly scattering. Histological findings suggest infiltration of tumor cells and macrophages from the subcapsular space into the precortical regions, which is clear evidence of early metastasis. The germination centers became more reactive, resulting in increased scattering in the OCT images.
The OCT images of lymph nodes from day 7 rats show that the new low-scattering subcapsular layer thickens and extends into the deeper regions of the node (Fig. 5b , position of the cross section is indicated by a green horizontal line in Fig. 5a ). The follicles are no longer visible, indicating a disruption of the follicular structure, and an increase of optical scattering from regions deeper in the lymph nodes. The histology results from this time point correlate very well with the OCT findings (Fig. 5d) . Lymph nodes were enlarged with aggregates of macrophages and tumor cells migrating from the subcapsular to paracortical regions (Fig. 5e) . Sheets of metastatic cells and macrophages infiltrating into the precortical regions of the lymph node correlate with the low scattering regions on OCT. The thickness of this layer increases as the tumor cells proliferate, eventually spreading throughout the lymph node. However, another area from the day 7 rat (Fig. 5c ; position of the cross section is indicated by a yellow horizontal line in Fig. 5a ), show only inflammatory changes resulting in low scattering inner regions with surrounding highly scattering cells. The corresponding histological observations report aggregates of macrophages in the cortical and paracortical regions, with compression of normal lymphoid tissue to the periphery and no tumor cells present (Fig. 5f) .
The lymph nodes from the day 9 after injection rats clearly show uniform high-scattering regions in the OCT images from the disruption of normal lymph node structure (Fig. 6) , indicating a metastatic tumor-filled node. Histology supports these observations, reporting total effacement of the nodal architecture, including the cortical, paracortical, and medullary regions, with a metastatic neoplastic mass of cells. This result is consistent with OCT and histology results from the pilot study, which showed complete metastatic invasion by day 12 and 13 after injection.
DISCUSSION
This controlled study demonstrated that OCT is capable of identifying early changes in lymph node morphology which are all well correlated to the corresponding histopathological findings. These include: larger follicles in reactive lymph nodes showing an inflammatory response, presence or disappearance of the outer capsule structure, appearance of a low scattering layer along the outer edges of the subcapsular space (indicating infiltration of macrophages), and infiltration of tumor cells in this region.
Three-dimensional OCT imaging of lymph nodes at varying stages of metastatic involvement show imagebased optical scattering features that strongly correlate with histological findings. These results suggest that 3-D OCT has potential for future in situ analysis of lymph nodes for staging cancer metastases intraoperatively. This OCT study was performed in a well-characterized preclinical animal model for lymph node metastases. The use of this animal model enabled the investigation of optical scattering and OCT image changes at various time-points and stages during metastatic involvement in a way that would not have be possible in human patients.
In this study, we performed ex vivo transcapsule 3-D OCT imaging of physically intact popliteal lymph nodes to observe their time-dependent changes from normal to grossly metastatic. Before this study, only images of discrete changes in time in various specimens were available, which could not fully track longitudinally the time-dependent optical changes that occur during metastases. The OCT images presented here clearly show the microscopic lymph node structure. The optical scattering and structural changes revealed by 3-D OCT from day 3 to day 9 after injection of tumor cells into the lymphatic system clearly indicate the progressive involvement of metastatic tumor cells and new tumor growth in the lymph nodes. The results also correlate well with the inflammatory and immunological changes observed in the capsule, precortical regions, follicles, and germination centers observed in the histopathological sections.
Identification of microstructural changes in OCT images corresponding to various stages of infiltration and more importantly, optical differences between normal nonreactive, reactive, and metastatic nodes was feasible using this controlled tumor metastasis model. Further work is required to investigate the biological variability between lymph nodes at any given time point. Ongoing studies are exploring the potential of high resolution OCT for detecting early micrometastasis of sizes \100 lm within the intact lymph nodes, which has clinical significance. 29 In current clinical practice, the sentinel lymph node or nodes associated with the tumor site are removed for postoperative histological assessment and staging of the cancer. Accurate staging based on lymph node involvement before treatment plays an integral part in planning further medical, surgical, and/or radiation interventions. We believe that the results obtained to date are very promising, and support OCT as a potentially cost-effective technique that could allow lymph node assessment in situ without having to physically resect and histologically process the tissue, Three-dimensional transcapsule imaging of lymph nodes and nodal micro-architecture demonstrate the potential of OCT for the intraoperative evaluation of lymph nodes where it may no longer be necessary to remove lymph nodes for postoperative assessment and cancer staging. OCT in combination with current lymph node mapping procedures could provide surgeons with a technology for future real-time intraoperative evaluation and staging of cancer in situ, using handheld surgical probes. 30, 31 Although OCT provides high-resolution images, it is at the expense of imaging penetration, which is less than other imaging modalities such as X-ray, MRI, PET, or ultrasound imaging, but still greater than other optical techniques such as bright-field, confocal, or multiphoton microscopy. The imaging depth penetration limits of OCT imaging is typically only 1-3 mm, depending on the optical properties of the tissue. Needlebased OCT probes, which could be inserted into lymph nodes either transcutaneously or during open surgical procedures, would allow the surgeon to image into deeper, unexposed lymph nodes. 32, 33 The data from this study therefore support the future investigation of a handheld surgical probe capable of in situ lymph node imaging and cancer staging, as well as needlebased probes that would be inserted into lymph nodes, allowing the surgeon to image deeper into the unexposed areas.
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